Search company, investor...
Paradromics company logo


Founded Year



Unattributed | Alive

Total Raised


Last Raised

$8.86M | 2 mos ago

About Paradromics

Paradromics develops brain-machine interfaces that will increase the data transmission rate between brains and computers. This will enable better treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation or spinal cord injuries. The company was founded in 2015 and is based in Austin, Texas.

Headquarters Location

4030 W Braker Ln Ste. 250

Austin, Texas, 78759,

United States


Missing: Paradromics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Paradromics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Paradromics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Paradromics is included in 4 Expert Collections, including Game Changers 2018.


Game Changers 2018

70 items


Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items


Digital Health

13,118 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Paradromics Patents

Paradromics has filed 1 patent.

The 3 most popular patent topics include:

  • Electrophysiology
  • Neurophysiology
  • Neuroscience
patents chart

Application Date

Grant Date


Related Topics




Neurophysiology, Neuroscience, Implants (medicine), Neurotechnology, Electrophysiology


Application Date


Grant Date



Related Topics

Neurophysiology, Neuroscience, Implants (medicine), Neurotechnology, Electrophysiology



Latest Paradromics News

Elon Musk Might Invest In Neuralink's Rival Synchron

Aug 23, 2022

Advertisement According to Engadget (via Reuters ), Elon Musk is seeking to close a deal with Synchron, which is one of the Neuralink rivals in the brain-machine interfaces market. These days, Elon Musk is making the headlines constantly. The richest man on the planet has recently backed out of the Twitter $44 billion deal and sparked litigation with the company. He now wants to do something unusual and invest in one of his company’s competitors. Of course, it’s unclear whether Musk wants to start a collaboration with Synchron or inject a part of his billion into it. Both sides have not yet responded to the news . However, Musk recently expressed his displeasure with the slow pace of progress on Neuralink. Investing in Synchron or starting a collaboration with them could help Musk to accelerate his brain-machine interface programs. Synchron is still evaluating the offer and hasn’t responded to it. Advertisement This is not the first time Elon Musk has been looking to invest in Neuralink rivals. Back in 2020, he reached Paradromics for a potential investment. However, they could never reach an agreement. Elon Musk wants to invest in Synchron Neuralink is one of the youngest Musk companies that was founded in 2016 to develop brain-machine interfaces. The company has already showcased its latest achievements through a Macaque monkey playing the Pong game. Neuralink also sought to start human trials in 2020, and back in January of this year, their job posting showed they were looking to hire a clinical trial director. Human testing of the brain-machine interfaces requires FDA approval. On the other hand, it seems that Synchron has surpassed Neuralink in the field of human trials. Dates back to July, the company announced the successful implementation of its brain-computer interface into the motor cortex of a human patient in the US. Synchron also confirmed the health of four people in Australia who had implants placed in their heads a year ago. Advertisement Moreover, Synchron has recently hired Neuralink co-founder Max Hodak, who left the company in 2021. Hodak has an advisory role in Synchron and has also invested a part of his own assets in it Share this page

Paradromics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Paradromics Rank

Paradromics Frequently Asked Questions (FAQ)

  • When was Paradromics founded?

    Paradromics was founded in 2015.

  • Where is Paradromics's headquarters?

    Paradromics's headquarters is located at 4030 W Braker Ln, Austin.

  • What is Paradromics's latest funding round?

    Paradromics's latest funding round is Unattributed.

  • How much did Paradromics raise?

    Paradromics raised a total of $66.53M.

  • Who are the investors of Paradromics?

    Investors of Paradromics include Prime Movers Lab, Dolby Family Ventures, Synergy Ventures, Westcott, Paycheck Protection Program and 11 more.

  • Who are Paradromics's competitors?

    Competitors of Paradromics include Neuralink and 2 more.

Compare Paradromics to Competitors

Neuralink Logo

Neuralink develops ultra-high bandwidth brain-machine interfaces to connect humans and computers. It intends to help people with paralysis. Its interface helps in treating and diagnosing neurological issues. The company was founded in 2016 and is based in San Francisco, California.

Kernel Logo

Kernel is a human intelligence company developing neuroprosthesis to mimic, repair, and improve cognition. Kernel's Neuroscience as a Service (NaaS) gives on-demand access to its brain recording technology.

Neurable Logo

Neurable develops VR technology that can be controlled by brain activity.

Synchron Logo

Synchron is a medical device company focused on the development of minimally invasive neuromodulation technology solutions. Synchron is developing an endovascular neural interface, the StentrodeTM.


Naolu Technology (also known as BrainUp) focuses on the application of human brain cutting-edge technologies such as brain-computer interface, early screening of brain health, and artificial intelligence of brain-like decision computing. The firm specializes in-depth in EEG sleep-aid, brain fMRI image analysis and industry real-time brain diagnosis solutions.

Momentis Surgical

Momentis Surgical develops a robotic arm that extends and improves upon the surgeon's natural movements. Moments Surgical was formerly known as Memic. The company was founded in 2012 and is based in Yehuda, Israel.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.